دورية أكاديمية
Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell Carcinoma
العنوان: | Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell Carcinoma |
---|---|
المؤلفون: | Hurwitz, Michael E., Markowski, Paul, Yao, Xiaopan, Deshpande, Hari, Patel, Jaymin, Mortazavi, Amir, Donadio, Alessia, Stein, Mark N., Kelly, William Kevin, Petrylak, Daniel Peter, Mehnert, Janice M. |
المصدر: | In Clinical Genitourinary Cancer December 2018 16(6):437-444 |
قاعدة البيانات: | ScienceDirect |
تدمد: | 15587673 |
---|---|
DOI: | 10.1016/j.clgc.2018.07.021 |